Your browser doesn't support javascript.
loading
Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program.
Procopio, Giuseppe; Prisciandaro, Michele; Iacovelli, Roberto; Cortesi, Enrico; Fornarini, Giuseppe; Facchini, Gaetano; Cartenì, Giacomo; Sabbatini, Roberto; Del Bene, Gabriella; Galli, Luca; Caserta, Claudia; Multari, Andrea Giovanni; Bregni, Marco; Massari, Francesco; Buti, Sebastiano; De Giorgi, Ugo; Zustovich, Fable; Milella, Michele; Calabrò, Fabio; Mancini, Maria Laura; Tortora, Giampaolo; Vernieri, Claudio; Santini, Daniele; Sorarù, Mariella; Ricotta, Riccardo; Masini, Cristina; Tucci, Marcello; Fedeli, Stefano Luzi; Ortega, Cinzia; Mecozzi, Antonella; Ratta, Raffaele; Sternberg, Cora N; Verzoni, Elena.
Afiliación
  • Procopio G; Department of Medical Oncology, Genitourinary Cancer Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Prisciandaro M; Department of Medical Oncology, Genitourinary Cancer Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Iacovelli R; Medical Oncology Unit, Azienda Ospedaliera Universitaria Integrata (AOUI), University of Verona, Verona, Italy.
  • Cortesi E; Department of Medical Oncology B, Policlinico Umberto I "Sapienza" University of Rome, Rome, Italy.
  • Fornarini G; Medical Oncology Department, IRCCS Azienda Ospedaliera Universitaria San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy.
  • Facchini G; Division of Medical Oncology, Department of Uro-Gynaecological Oncology, Istituto Nazionale Tumori Fondazione G. Pascale (IRCCS), Naples, Italy.
  • Cartenì G; Oncology Unit, Antonio Cardarelli Hospital, Naples, Italy.
  • Sabbatini R; Department of Oncology and Hematology and Respiratory Disease, University Hospital, Modena, Italy.
  • Del Bene G; Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy.
  • Galli L; Department of Medical Oncology 2, Istituto Toscano Tumori, Pisa, Italy.
  • Caserta C; Oncology Department, Santa Maria Hospital, Terni, Italy.
  • Multari AG; Medical Oncology Unit, University of Siena, Siena, Italy.
  • Bregni M; Ospedale di Circolo di Busto Arsizio, Busto Arsizio, Italy.
  • Massari F; Division of Oncology, S Orsola-Malpighi Hospital, Bologna, Italy.
  • Buti S; Medical Oncology Unit, University Hospital of Parma, Italy.
  • De Giorgi U; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Zustovich F; San Martino Hospital, Medical Oncology, Belluno, Italy.
  • Milella M; Medical Oncology Unit, Istituto Nazionale Tumori Regina Elena (IFO), Rome, Italy.
  • Calabrò F; Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy.
  • Mancini ML; Department of Medical Oncology B, Policlinico Umberto I "Sapienza" University of Rome, Rome, Italy.
  • Tortora G; Medical Oncology Unit, Azienda Ospedaliera Universitaria Integrata (AOUI), University of Verona, Verona, Italy.
  • Vernieri C; Department of Medical Oncology, Genitourinary Cancer Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Santini D; Medical Oncology Unit, Campus Bio-Medico University of Rome, Rome, Italy.
  • Sorarù M; Medical Oncology Unit, Camposampiero, Italy.
  • Ricotta R; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Masini C; Oncology Unit, Department of Oncology and Advanced Technologies, Arcispedale Santa Maria Nuova-IRCCS, Reggio Emilia, Italy.
  • Tucci M; Division of Medical Oncology, San Luigi Gonzaga Hospital, Department of Oncology, University of Turin, Orbassano, Turin, Italy.
  • Fedeli SL; Department of Medical Oncology, AOU Ospedali Riuniti, Università Politecnica delle Marche, Presidio San Salvatore, Pesaro, Italy.
  • Ortega C; Division of Oncology, Institute for Cancer Research and Treatment, ASL CN2 Alba-Bra, Alba, Italy.
  • Mecozzi A; Oncology Department, S. Giovanni Calibita' Fatebenefratelli Isola Tiberina Hospital, Rome, Italy.
  • Ratta R; Department of Medical Oncology, Genitourinary Cancer Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Sternberg CN; Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy.
  • Verzoni E; Department of Medical Oncology, Genitourinary Cancer Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. Electronic address: elena.verzoni@istitutotumori.mi.it.
Clin Genitourin Cancer ; 16(4): e945-e951, 2018 08.
Article en En | MEDLINE | ID: mdl-29753637
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Piridinas / Carcinoma de Células Renales / Neoplasias Renales / Anilidas Tipo de estudio: Observational_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Clin Genitourin Cancer Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Piridinas / Carcinoma de Células Renales / Neoplasias Renales / Anilidas Tipo de estudio: Observational_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Clin Genitourin Cancer Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Italia